Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.60
-0.10 (-1.75%)
Mar 6, 2026, 4:00 PM EST - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $355.62 million as of March 6, 2026. Its market cap has decreased by -6.69% in one year.
Market Cap
355.62M
Enterprise Value
211.51M
1-Year Change
-6.69%
Ranking
Category
Stock Price
$5.60
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $355.62M, a decrease of -10.59%. That is a compound annual growth rate of -2.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 355.62M | 2.75% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 378.35M |
| Aclaris Therapeutics | 369.02M |
| LENZ Therapeutics | 365.15M |
| Candel Therapeutics | 361.84M |
| Bicycle Therapeutics | 360.71M |
| Absci | 357.88M |
| Climb Bio | 343.52M |
| Neurogene | 343.41M |